Previous Article | Next Article 
Journal of Virology, October 2000, p. 9610-9616, Vol. 74, No. 20
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Prevention of Adult T-Cell Leukemia-Like
Lymphoproliferative Disease in Rats by Adoptively Transferred T Cells
from a Donor Immunized with Human T-Cell Leukemia Virus Type 1 Tax-Coding DNA Vaccine
Takashi
Ohashi,1
Shino
Hanabuchi,1
Hirotomo
Kato,1
Hiromi
Tateno,1
Fumiyo
Takemura,1,2
Tomonori
Tsukahara,1
Yoshihiro
Koya,1
Atsuhiko
Hasegawa,1
Takao
Masuda,1 and
Mari
Kannagi1,2,*
Department of Immunotherapeutics, Tokyo
Medical and Dental University, Medical Research Division, Tokyo
113,1 and CREST, Japan Science and
Technology Corporation, Saitama 332,2 Japan
Received 7 March 2000/Accepted 17 July 2000
Human T-cell leukemia virus type 1 (HTLV-1) causes adult T-cell
leukemia (ATL) in infected individuals after a long incubation period.
To dissect the mechanisms of the development of the disease, we have
previously established a rat model of ATL-like disease which allows
examination of the growth and spread of HTLV-1 infected tumor cells, as
well assessment of the effects of immune T cells on the development of
the disease. In the present study, we induced HTLV-1 Tax-specific
cytotoxic T lymphocyte (CTL) immunity by vaccination with Tax-coding
DNA and examined the effects of the DNA vaccine in our rat ATL-like
disease model. Our results demonstrated that DNA vaccine with Tax
effectively induced Tax-specific CTL activity in F344/N Jcl-rnu/+
(nu/+) rats and that these CTLs were able to lyse HTLV-1
infected syngeneic T cells in vitro. Adoptive transfer of these immune
T cells effectively inhibited the in vivo growth of HTLV-1-transformed
tumor in F344/N Jcl-rnu/rnu (nu/nu) rats inoculated with a rat HTLV-1
infected T cell line. Vaccination with mutant Tax DNA lacking
transforming ability also induced efficient anti-tumor immunity in this
model. Our results indicated a promising effect for DNA vaccine with
HTLV-1 Tax against HTLV-1 tumor development in vivo.
*
Corresponding author. Mailing address: Department of
Immunotherapeutics, Tokyo Medical and Dental University, Medical
Research Division, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113, Japan. Phone: 81 (3) 5803-5798. Fax: 81 (3) 5803-0235. E-mail:
kann.impt{at}med.tmd.ac.jp.
Journal of Virology, October 2000, p. 9610-9616, Vol. 74, No. 20
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Takatsuka, N., Hasegawa, A., Takamori, A., Shimizu, Y., Kato, H., Ohashi, T., Amagasa, T., Masuda, T., Kannagi, M.
(2009). Induction of IL-10- and IFN-{gamma}-producing T-cell responses by autoreactive T-cells expressing human T-cell leukemia virus type I Tax. Int Immunol
21: 1089-1100
[Abstract]
[Full Text]
-
Takayanagi, R., Ohashi, T., Yamashita, E., Kurosaki, Y., Tanaka, K., Hakata, Y., Komoda, Y., Ikeda, S., Tsunetsugu-Yokota, Y., Tanaka, Y., Shida, H.
(2007). Enhanced Replication of Human T-Cell Leukemia Virus Type 1 in T Cells from Transgenic Rats Expressing Human CRM1 That Is Regulated in a Natural Manner. J. Virol.
81: 5908-5918
[Abstract]
[Full Text]
-
Komori, K., Hasegawa, A., Kurihara, K., Honda, T., Yokozeki, H., Masuda, T., Kannagi, M.
(2006). Reduction of Human T-Cell Leukemia Virus Type 1 (HTLV-1) Proviral Loads in Rats Orally Infected with HTLV-1 by Reimmunization with HTLV-1-Infected Cells.. J. Virol.
80: 7375-7381
[Abstract]
[Full Text]
-
Kobayashi, H., Ngato, T., Sato, K., Aoki, N., Kimura, S., Tanaka, Y., Aizawa, H., Tateno, M., Celis, E.
(2006). In vitro Peptide Immunization of Target Tax Protein Human T-Cell Leukemia Virus Type 1-Specific CD4+ Helper T Lymphocytes.. Clin. Cancer Res.
12: 3814-3822
[Abstract]
[Full Text]
-
Harashima, N., Tanosaki, R., Shimizu, Y., Kurihara, K., Masuda, T., Okamura, J., Kannagi, M.
(2005). Identification of Two New HLA-A*1101-Restricted Tax Epitopes Recognized by Cytotoxic T Lymphocytes in an Adult T-Cell Leukemia Patient after Hematopoietic Stem Cell Transplantation. J. Virol.
79: 10088-10092
[Abstract]
[Full Text]
-
Nomura, M., Ohashi, T., Nishikawa, K., Nishitsuji, H., Kurihara, K., Hasegawa, A., Furuta, R. A., Fujisawa, J.-i., Tanaka, Y., Hanabuchi, S., Harashima, N., Masuda, T., Kannagi, M.
(2004). Repression of Tax Expression Is Associated both with Resistance of Human T-Cell Leukemia Virus Type 1-Infected T Cells to Killing by Tax-Specific Cytotoxic T Lymphocytes and with Impaired Tumorigenicity in a Rat Model. J. Virol.
78: 3827-3836
[Abstract]
[Full Text]
-
Harashima, N., Kurihara, K., Utsunomiya, A., Tanosaki, R., Hanabuchi, S., Masuda, M., Ohashi, T., Fukui, F., Hasegawa, A., Masuda, T., Takaue, Y., Okamura, J., Kannagi, M.
(2004). Graft-versus-Tax Response in Adult T-Cell Leukemia Patients after Hematopoietic Stem Cell Transplantation. Cancer Res.
64: 391-399
[Abstract]
[Full Text]
-
Hasegawa, A., Ohashi, T., Hanabuchi, S., Kato, H., Takemura, F., Masuda, T., Kannagi, M.
(2003). Expansion of Human T-Cell Leukemia Virus Type 1 (HTLV-1) Reservoir in Orally Infected Rats: Inverse Correlation with HTLV-1-Specific Cellular Immune Response. J. Virol.
77: 2956-2963
[Abstract]
[Full Text]
-
Ohashi, T., Hanabuchi, S., Suzuki, R., Kato, H., Masuda, T., Kannagi, M.
(2002). Correlation of Major Histocompatibility Complex Class I Downregulation with Resistance of Human T-Cell Leukemia Virus Type 1-Infected T Cells to Cytotoxic T-Lymphocyte Killing in a Rat Model. J. Virol.
76: 7010-7019
[Abstract]
[Full Text]
-
Haupt, K., Roggendorf, M., Mann, K.
(2002). The Potential of DNA Vaccination against Tumor-Associated Antigens for Antitumor Therapy. Exp. Biol. Med.
227: 227-237
[Abstract]
[Full Text]
-
Furuta, R. A., Sugiura, K., Kawakita, S., Inada, T., Ikehara, S., Matsuda, T., Fujisawa, J.-i.
(2002). Mouse Model for the Equilibration Interaction between the Host Immune System and Human T-Cell Leukemia Virus Type 1 Gene Expression. J. Virol.
76: 2703-2713
[Abstract]
[Full Text]
-
Hanabuchi, S., Ohashi, T., Koya, Y., Kato, H., Hasegawa, A., Takemura, F., Masuda, T., Kannagi, M.
(2001). Regression of Human T-cell Leukemia Virus Type I (HTLV-I)-Associated Lymphomas in a Rat Model: Peptide-Induced T-Cell Immunity. JNCI J Natl Cancer Inst
93: 1775-1783
[Abstract]
[Full Text]